Sep. 27 at 2:14 AM
$AYTU $AYTU Josh Dipshit quote. “We are thrilled to report our FY25 Full Year and Q4 results today! Aytu BioPharma delivered its 9th straight quarter - and 3rd straight year - of positive Adjusted EBITDA, and this year we posted annual revenue of over
$66M!”
This Moron lives in a bubble. EBITDA is a non-GAAP (Generally Accepted Accounting Principles) metric, so companies can calculate it in non-standard ways. Some companies report Adjusted EBITDA that excludes non-recurring expenses, but this can give a misleadingly rosy picture of performance by downplaying frequent one-time costs. Companies with high debt or aging assets can use EBITDA to make their financial health look better than it is. By excluding interest and depreciation, a struggling business can appear more profitable.
